The Society for Immunotherapy of Cancer's (SITC) Board of Directors have full responsibility for the management, direction and control of the business, policies and affairs of the society, subject only to limitations set forth in the society's Articles of Incorporation and Bylaws.
*As of the 2017 SITC Board of Directors election, terms for incoming board members shifted to having a Jan. 1 start date of the proceeding new year. An asterisk is denoted below for each of the new board members who began their term on Jan. 1.
PresidentUniversity of Pittsburgh
Vice President Yale School of Medicine
Secretary/TreasurerCity of Hope
Immediate Past PresidentReplimune Group Inc.
Istituto Nazionale Tumori-Fondazione 'G. Pascale'
Columbia University Medical Center
Johns Hopkins University
Universite Pierre Et Marie Curie, Sorbonne Universites
Bill & Melinda Gates Medical Research Institute
University of Wisconsin Carbone Cancer Center
Princess Margaret Cancer Centre
University of LausanneEditor-in-ChiefJournal for ImmunoTherapy of Cancer
National Cancer Institute (NCI)NCI Liaison
US Food and Drug Administration, OHOPFDA Liaison
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: firstname.lastname@example.org